VERACYTE, INC. Cash and Restricted Cash
VERACYTE, INC. (VCYT) had Cash and Restricted Cash of $301.19 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-31
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $301.19M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $264.79M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $364.23M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $317.21M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $301.19M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $264.79M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $364.23M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $317.21M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $221.15M 10-Q · filed 2026-07-31 |
| 2025-03-31 | $187.76M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $240.63M 10-Q · filed 2026-07-31 |
| 2024-09-30 | $275.16M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $237.00M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $210.27M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $217.33M 10-K · filed 2026-02-26 |
| 2023-09-30 | $203.33M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $192.03M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $178.64M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $155.00M 10-K · filed 2026-02-26 |
| 2022-09-30 | $170.86M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $154.20M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $164.36M 10-Q · filed 2023-05-05 |
| 2021-12-31 | $173.95M 10-K · filed 2025-02-28 |
| 2021-09-30 | $164.78M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $328.29M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $324.81M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $349.97M 10-K · filed 2024-02-29 |
| 2020-09-30 | $345.68M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $148.05M 10-Q · filed 2021-07-29 |
| 2020-03-31 | $153.74M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $159.92M 10-K · filed 2023-03-01 |
| 2019-09-30 | $196.26M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $193.25M 10-Q · filed 2020-07-30 |
| 2019-03-31 | $68.44M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $78.60M 10-K · filed 2022-02-28 |
| 2018-09-30 | $78.45M 10-Q · filed 2019-10-22 |
| 2018-06-30 | $24.36M 10-Q · filed 2019-07-30 |
| 2018-03-31 | $27.75M 10-Q · filed 2019-04-30 |
| 2017-12-31 | $34.49M 10-K · filed 2021-02-22 |
| 2017-09-30 | $41.80M 10-Q · filed 2018-10-29 |
| 2017-06-30 | $47.19M 10-Q · filed 2018-07-23 |
| 2016-12-31 | $59.94M 10-K · filed 2020-02-25 |
| 2015-12-31 | $39.80M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |